Post-exposure chemoprophlaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection

Journal of Medical Primatology

Volumn 29, Issue 3-4, 2000, Pages 248-258

  Tsai, Che Chung ^a   Emau, Peter ^a   Sun, Joseph C ^a   Beck, Thomas W ^a   Tran, Chy Anh ^a   Follis, Kathryn E ^a   Bischofberger, Norbert ^b   Morton, William R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GILEAD SCIENCES   (United States)

Author keywords

Anti retroviral drugs; HIV; Immune response; Monkeys; SIV

Indexed keywords

ADEFOVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; ADENINE; DRUG DERIVATIVE; ORGANOPHOSPHORUS COMPOUND; PHOSPHONIC ACID DERIVATIVE; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LYMPHOCYTE COUNT; MACACA; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SYMPTOM; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS INFECTION; ANIMAL; DISEASE MODEL; DISEASE TRANSMISSION; HUMAN; ISOLATION AND PURIFICATION; MONKEY DISEASE; POLYMERASE CHAIN REACTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

ADENINE; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; HIV INFECTIONS; HUMANS; MACACA FASCICULARIS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE INHIBITORS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0033626536     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0684.2000.290318.x     Document Type: Article

References (20)

1. + cells from HIV-infected individuals can suppress productive infection of macrophages independent of β-chemokines
2. Isolation of a lentivirus from a macaque with lymphoma: Comparison to HTL V-III/LAV and other lentiviruses
3. Inoculation of baboons and macaques with simian immunodeficiency virus/mne, a primate lentivirus closely related to human irnmunodeficiency virus type 2
4. + cell suppressor factors and cytotoxic T lymphocytes during HIV infection
5. Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/smm)
6. SIV(smmPBj14): An atypical lentivirus
7. + T cells
8. Infection of rhesus and cynomolgus macaques with a rapidly fatal SIV (SIVsmm/PBj) isolate from sooty mangabeys
9. + cell anti-HIV: Nonlytic suppression of virus replication
10. Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay
11. + T cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages
12. Protective immunity against HIV infection: Has nature done the experiment for us?
13. Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)-adenine against simian immunodeficiency virus infection in macaques
14. Prevention of SIV infection in macaques by (R)-9-(2-phosphonyl-methoxypropyl)adenine
15. Infectivity and pathogenesis of titrated dosages of simian immunodeficiency virus (SIV) experimentally inoculated into longtailed macaques (Macaca fascicularis)
16. In vitro screening for antiretroviral agents against simian immunodeficiency virus (SIV)
17. Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus
18. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl)adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment
19. + lymphocytes can control HIV infection in vitro by suppressing virus replication
20. + cells in human immunodeficiency virus type 1 pathogenesis: Cytolytic and noncytolytic inhibition of viral replication